A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium Compared With Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease

NCT02207829 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1017

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Umeclidinium
DRUG: Umeclidinium matching placebo
DRUG: Tiotropium
DRUG: Tiotropium matching placebo

Sponsor

GlaxoSmithKline